Oxycodone, a popularly used opioid for treating pain, is widely abused. Other drugs of abuse have been shown to affect time perception, which, in turn, may affect sensitivity to future consequences. This may contribute to continued use. This study evaluated the effect of oxycodone on time perception in normal healthy volunteers. For this withinsubject, double-blind design study, participants performed a temporal reproduction task before and after receiving placebo or oxycodone (15 mg, orally) over six outpatient sessions. Participants were first trained with feedback to reproduce three standard intervals (1.1, 2.2, and 3.3 s) in separate blocks by matching response latency from a start signal to the duration of that block's standard interval. During testing, participants were instructed to reproduce the three intervals from memory without feedback before and after drug administration. Oxycodone significantly lengthened time estimations for the two longer intervals relative to placebo. These results suggest that opioids alter temporal processing for intervals greater than 1 s, raising questions about the effect of these drugs on the valuation of future consequences.
Introduction
Oxycodone, an opioid agonist, is used clinically to treat patients with moderate-to-severe persistent pain (Riley et al., 2008) . It is also emerging as a substance of abuse (Cicero et al., 2007) . Addicts of opiates, such as heroin, are said to have shortened time horizons, leading to devaluation of future consequences, poor decision making, and continued drug use (Petry et al., 1998) . Devaluation of future outcomes has been suggested to be related to altered time perception in drug users (Takahashi 2005 (Takahashi , 2006 Wittmann et al., 2007; Wittmann and Paulus, 2008) . After all, one of the most salient factors in the choice between receiving a small immediate reward (e.g. intoxication after drug administration) and a larger delayed reward (e.g. health benefits associated with abstinence) is the distance in time between the two rewards. The notion that delay discounting is related to interval timing is supported by functional imaging findings showing that brain areas associated with intertemporal choice with delays of less than 1 year are some of those also involved in interval timing, or time perception in the seconds-to-minutes range (Wittmann et al., 2007) . Acute administration of Damphetamine, an indirect dopamine agonist, which is thought to shorten time estimations in rats (Meck, 1996) , has also been shown to decrease impulsivity on a delay discounting task when modest doses (10 and 20 mg) are administered orally to normal healthy volunteers (De Wit et al., 2002) . This decrease in impulsivity on delay discounting was accompanied by a nonsignificant trend for underestimations of time intervals. If a drug of abuse, such as oxycodone, alters the experience of time, for example, by making a given period of time seem longer, this may cause future rewards to seem even further in the distance than they really are, and the impulsive choice that much more attractive.
The aim of this study was to examine the effects of oxycodone on the accuracy of interval timing in human volunteers. Interval timing research over the past few decades has been dominated by Scalar Expectancy Theory (SET; Gibbon, 1977) . In this model, a pacemaker produces signals that count off the time as it passes. These signals are collected by an accumulator that keeps track of how many signals have been produced during the interval being timed. Between the pacemaker and the accumulator is an attention mechanism, such that attention 'closes the switch' between the pacemaker and the accumulator and allows signals to reach the accumulator. The number of signals in the accumulator is transferred to working memory, and is compared with a reference memory for pacemaker signals for the relevant time. When the number of signals is close to the reference memory value, within some threshold, the appropriate response is made. Thus, there are four stages that can be affected by a given manipulation such as drug administration, the pacemaker/accumulator stage, the attentional switch, the reference memory stage, or the decision (threshold) stage. Drugs that affect cognitive functions, such as attention or memory, can have specific effects on various stages of the SET model. Some reports suggest that oxycodone may affect some of these cognitive functions under specific circumstances (Friswell et al., 2008; Cherrier et al., 2009) , but others suggest that these effects are unreliable at best (for review, see Zacny, 1995; Zacny and Gutierrez, 2003) , leaving open the question of whether oxycodone can affect interval timing.
The effect of opioid agonists other than oxycodone, such as morphine and heroin, on time perception has been studied with mixed results. Rhesus monkeys were trained to perform a temporal response differentiation task, in which they were required to hold a lever down for not less than 10 s, but not more than 14 s, to gain a reward. Morphine disrupted temporal response differentiation performance, such that animals released the lever earlier than they would under placebo conditions (Schulze and Paule, 1991) . In the scalar timing framework, this suggests either a speeded clock, which would lengthen estimations of the current time or a shortened memory for the criterion duration, or a lowered threshold for responding. Similarly, heroin-dependent volunteers in the first few days of withdrawal made short reproductions of a 12-s interval compared with normal healthy volunteers (Aleksandrov, 2005) , suggesting a shortening of the perception of time when heroin is withheld. Some studies with pigeons suggest that time may be overestimated in response to morphine administration, but alternative accounts based on the ability of morphine to change response rates and discrimination accuracy complicate the interpretation of these studies (Knealing and Schaal, 2002; Odum and Ward, 2004; Ward and Odum, 2005) . Thus, more work needs be done to clarify the impact, if any, which opiates have in interval timing.
Oxycodone may have an effect on interval timing, but at which range? An emerging theme in interval timing research is the distinction between automatic and cognitively controlled timing (for review, see Lewis and Miall, 2003) . The suggestion is that timing of about a second or less is automatic, or mainly under the control of the motor system. In contrast, cognitively controlled timing involves intervals of greater than approximately 1 s, and engages cognitive mechanisms such as working memory and attention. The differences in putative timing mechanisms and results of perturbations to these systems, depending on the stimulus duration, have been termed range effects (Gibbon et al., 1997) . One line of evidence for these range effects is the difference in the effect of drugs upon timing of various intervals. For example, the benzodiazepine midazolam (Rammsayer, 1999) and the N-methyl-D-aspartic acid (NMDA) receptor antagonist, memantine (Rammsayer, 2006) , both disrupt timing of intervals of approximately 1 s, but not intervals in the millisecond range. Benzodiazepines (Cole and Hillman, 1994) and NMDA receptor antagonists (Adler et al., 1998; Morgan et al., 2004) have been shown to interfere with working memory function. In part because of this, it has been argued that drugs that affect cognitive processes such as attention and working memory consequently affect cognitively controlled timing, but not automatic timing (Poppel, 1997; Rammsayer, 1999; Madison, 2001; Lewis and Miall, 2003) . Oxycodone has been shown to have detrimental effects on attention and working memory in healthy participants generally (digit symbol and number sequencing; Zacny and Lichtor, 2008) in those over the age of 35 years (digit symbol and number letter sequencing; Cherrier et al., 2009) , and women but not men at a dose of 5 mg (reverse digit span; Friswell et al., 2008) . Therefore, these studies suggest that oxycodone could affect timing in the suprasecond range (> 1 s, also characterized as cognitively controlled timing) through one or more of these processes.
This study evaluated how oxycodone affects time perception in humans by administering a temporal reproduction task before and after administration of placebo or active oxycodone. The choice of tasks was guided by a previous study showing the efficacy of singleinterval production (SIP) tasks in characterizing timing deficits in impaired Malapani et al., 2002) and unimpaired (Rakitin et al., , 2005 Rakitin, 2005) human populations. Participants learned the time intervals to be reproduced, and then were tested on their memory for those intervals. Drug or placebo was given, and then participants were tested again on their memory for the interval. The results of this study shed light on the role of opiates in interval timing.
Methods

Participants
Volunteers were recruited through local newspaper advertisements and were invited to the laboratory for screening after meeting preliminary inclusion/exclusion criteria in a telephone screen. During screening, participants received psychiatric and medical evaluations, and provided detailed drug use and medical histories. Participants were required to be healthy as determined by a physical examination, which included urinalysis, blood chemistries, and an electrocardiogram; to be between 21-55 years of age; normal body weight as determined within 20% of the body weight for appropriate frame according to 1983 Metropolitan Weight tables; have been prescribed and used opioids for medical purposes at least twice with no serious adverse effects; and female participants had to be using an effective form of birth control. Exclusion criteria included a recent conviction of a crime of violence; current axis I psychopathology or significant axis II disorder; currently pregnant, pregnant within the past 6 months, or nursing as determined by selfreport, and plasma and urine pregnancy tests; current use of psychotropic medications; history or current opioid dependence or recreational opioid use; chronic pain or use of over the counter analgesics more than four times each month; high blood pressure; sensitivity, allergy or contraindication to opioids; and meeting the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, revised criteria for substance abuse or dependence in the past 2 years. Once eligibility was verified, participants were enrolled in the study only after written informed consent was obtained. All study procedures were approved by the Institutional Review Board of the New York State Psychiatric Institute and were in accord with the Declaration of Helsinki. Participants were compensated for their time.
Task
A SIP training block included 20 identical synchronization trials that presented pairs of tones separated by one of three target intervals, either 1.1 (e.g. 'short'), 2.2 (e.g. 'medium'), or 3.3 s (e.g. 'long'). A yellow square on the screen cued the beginning of the synchronization trials, and the first of the tones occurred after an average of 0.675 s (0.450-0.900 s, in equally probable 0.150-s increments).
Participants were instructed to skip as many trials as necessary to get a feel for the target interval, and then respond in synchrony to the second tone. Trials in which participants did not respond terminated after four times the target interval. The cue turned red for 0.500 s with each response or after a time-out, signaling the end of a trial, and then cleared. SIP-testing blocks included 20 trials. Each testing trial presented a single tone, and participants attempted to respond, so their response latency after the tone matched the target interval established by the tone pairs. A green square cued the start of testing trials. The square turned red after a response or a time out. A 0.500-s intertrial interval separated all trials. Counting all delays, tone cues followed the preceding trials' response by an average of 1.675 s.
Instructions presented on the screen preceding each block indicated the cueing and response contingencies for that task. The instructions did not indicate the duration of the target interval. The instructions cleared after a key press. The task block began 0.500 s after the instructions cleared.
Procedure
Before each testing session, participants provided a urine sample, which was tested for morphine, methadone, benzoylecgonine, amphetamine, methamphetamine, phencyclidine, barbiturates, tetrahydrocannabinol, and benzodiazepines, and a breathalyzer test was administered. In addition, a urine pregnancy test was administered to female participants before each session. Cigarette smokers were allowed to smoke one cigarette 15 min before physiological monitoring and task participation. Before the session, a baseline balancing task was administered, a standardized breakfast was provided, and physiological monitoring began and continued throughout the session (oxygen saturation measured continuously and recorded every 1 min; blood pressure measured and recorded every 15 min). On each testing day, participants were trained and tested on reproduction of all three target intervals. Participants completed one training block for each target interval, and then completed two testing blocks for each target interval (pretest). Next, 75 min after capsule administration, two more testing blocks for each target interval were completed (post-test). Previous results (Zacny and Gutierrez, 2003) suggest that the optimal effect of oxycodone on cognitive measures occurs at around this time. The order of target interval testing with immediate and delayed testing phases was the same, and was randomized for each participant. All participants received a field sobriety test before discharge from each laboratory session, and if there was any indication of intoxication, a car service was called to take the participant home.
Study design
During one week, effects of oxycodone on the task performance were assessed on 3 consecutive days, and during another week, placebo capsules were administered and performance was assessed on 3 consecutive days. Each testing week was separated by a full week during which no medications were administered. The order of the oxycodone and placebo weeks was randomized across participants. At the end of each session, participants received one oxycodone (oxycodone week), or placebo capsule (placebo week) in a child-proof bottle. Participants were instructed to take the capsule in the evening. The purpose of evaluating effects of oxycodone over 3 consecutive days and the administration of the evening doses were to assess tolerance development to effects of oxycodone, the primary aim of the larger study. As part of the general study, participants received increasing doses of oxycodone at 45-min intervals (three participants received 0, 10, and 30 mg/70 kg of oxycodone, and eight received 0, 5, and 15 mg/70 kg of oxycodone) on the day before and the day after the 3 consecutive dosing days described for this study. On these days, analgesic effects of oxycodone were assessed using the cold pressor test, and measurements of the drug's subjective and cognitive effects were obtained. Results of these tests will be published separately.
Drug
Oxycodone capsules (placebo or 15 mg) were packaged into size 00 opaque capsules with lactose filler by the New York State Psychiatric Institute Research Pharmacy. Participants were given capsules to be taken at home in a child-proof bottle. On Mondays and Fridays, oxycodone HCl [Oxyfast Immediate-Release Oral Concentrate Solution (20 mg/ml), Purdue Pharma, Stamford, Connecticut, USA] was prepared at doses of 0, 5, and 15 mg per 70 kg of oxycodone. The solution was mixed in orange-flavored gatorade with 1 ml of peppermint oil floating on top to mask the taste of the drug. A total volume of 200 ml was administered at each dosing, and was consumed within 5 min. The oxycodone doses used for this study were within the recommended dose range of orally administered oxycodone for treating pain (5-30 mg every 6 h; Physicians' Desk Reference, 2009), and were previously tested safely in normal healthy volunteers (Zacny and Gutierrez, 2003) .
Data analysis
The dependent variables were the intracondition, intraindividual proportional error of mean response latencies ((latency -target)/target), to allow direct comparison among time intervals, and the coefficient of variation (CV; standard deviation/mean) of response latencies. Standard data treatment excluded the first two responses in each block, as well as the fastest and slowest latency in each condition, to remove spurious variability in response. Hypotheses were tested for each variable using separate analyses of variance. The following were withinsubjects factors: target duration (1.1, 2.2, and 3.3 s); task phase (predose testing or pretest, postdose testing or posttest); dose (0 or 15 mg), and test days (days 1, 2, and 3). Planned contrasts on the duration and test days factors were chosen to look for differences between the shortest duration and the other two durations (range effects), or between day 1 and later days (learning or tolerance effects).
Results
Participants
Twenty-one individuals were enrolled in the study and 13 participants completed it. Two were excluded because predrug administration training performance indicated they did not learn the intervals to be timed. Thus, 11 participants (eight men; three women; nine white; two Hispanic; average age of 30 years with a range of 22-51 years) contributed to the reported data. Nine of the included participants reported previous marijuana use (last use ranged from 6 weeks to 25 years before screening, with maximum lifetime use ranging from three times ever used to once per week). Past cocaine use was reported by two of the included participants (last use ranged from 4 years to 25 years before the study screening process, with maximum use ranging from twice ever used to once per week). One included participant reported past recreational use of ecstasy and Ritalin (each drug was used once: ecstasy, 8 years before study screening and Ritalin, 2 months before study screening). Daily tobacco use was reported by six of the included participants (range 1 week-10 days). Of the eight volunteers who discontinued study participation, two dropped out due to medication side-effects (excessive sedation, nausea, vomiting, and intense headache), one was discontinued due to elevated blood pressure during the cold pressor test, and five discontinued for unknown reasons.
Effects of oxycodone on interval reproduction
Differences in proportional errors between 15 mg of oxycodone and placebo, for each of the three target intervals, collapsed over dosing day, are shown in Figure 1 . There was a significant interaction between duration, testing phase, and dose of drug administration, such that the pretest was different from the post-test, depending on whether participants received oxycodone or placebo [F(2,20) = 3.9, P < 0.05], for the 2.2 and 3.3-s intervals only (contrast, 1.1 s vs. others Â phase Â dose; F(1,10) = 7.2, P < 0.05]. For the 2.2 and 3.3-s intervals, temporal reproductions were longer after 15 mg of oxycodone administration than after placebo. A significant main effect for duration was found [F(2,20) = 4.7, P < 0.05], and the contrast testing whether the 1.1-s interval was different from the others was marginally significant [F(1,10) = 5.0, P = 0.05]. This indicates that reproductions of the 1.1-s interval had smaller proportional errors than those for the other two intervals overall. The duration Â phase interaction was also significant [F(2,20) = 9.3, P < 0.05]; the 1.1-s interval showed a different pattern between pretest and post-test than the other times [contrast, 1.1 s vs. other intervals Â phase; F(1,10) = 12.9, P < 0.05]. Specifically, reproductions of the 1.1-s interval were proportionally shorter in the posttest condition compared with those of the other two intervals. There were no significant effects for the test day Â dose interaction, thus results presented in Figure 1 are collapsed over the three test days. A complex significant interaction arose among the four factors, duration, phase, test day, and dose [F(4,40) = 2.6, P < 0.05]. Planned contrasts did not reveal a pattern.
CV results are shown in Table 1 . There was a significant main effect for dose [F(1,10) = 5.1, P < 0.05], indicating that intraindividual variability was greater on days when oxycodone was administered as opposed to placebo. There was also a significant main effect for duration [F(2,20) = 9.4, P < 0.05], such that reproductions of the 1.1-s interval were more variable than those for other times [contrast, 1.1 s vs. other intervals; F(1,10) = 11.6, P < 0.05].
Discussion
Reproductions of previously learned time intervals greater than approximately 1 s are lengthened after oral administration of 15-mg oxycodone compared with placebo. This is in line with previous findings in animals, which suggest that other opioid agonists, such as morphine (Schulze and Paule, 1991; Knealing and Schaal, 2002; Odum and Ward, 2004; Ward and Odum 2005) , lengthen time estimations. Conversely, heroin withdrawal shortens time estimations in humans (Aleksandrov, 2005) .
Our findings lend further support to range theories that suggest different mechanisms for timing intervals of approximately 1 s or lower and those longer than approximately 1 s. We found that 15 mg of oxycodone Oxycodone and interval timing Gooch et al. 357 selectively lengthens temporal reproductions of intervals greater than approximately 2 s while leaving the approximately 1 s estimations unaffected. This is similar to findings for benzodiazepines (Rammsayer, 1999) and NMDA receptor antagonists (Rammsayer, 2006) , which also affect working memory function. The picture emerges that drugs that influence working memory also affect time perception of intervals greater than 1 s, or what is termed cognitive timing. One can speculate regarding the possible mechanisms of the effect of oxycodone on suprasecond timing. m-opioid antagonists enhance working memory performance in rats (Canli et al., 1990) and evidence in rats also shows that morphine administration interferes with working memory on an eight-arm maze task (Braida et al., 1994) . Furthermore, working memory function has been shown to be compromized in middle aged and older adults (age Z 35 years) in response to 10-mg oxycodone administration (Cherrier et al., 2009) and in women in response to 5-mg oxycodone administration (Friswell et al., 2008) , although results with oxycodone and other opioids in younger adults have been mixed (for review, see Zacny, 1995; Zacny and Gutierrez, 2003) . Not only has working memory been suggested to be a part of the machinery supporting time perception (Baudouin et al., 2006a (Baudouin et al., , 2006b , it has also been proposed to rely on the same neural mechanism (Lewis and Miall, 2006) . In a neural model based on the Multiple Time Scales cognitive model of timing (Staddon, 2005) , Lewis and Miall, 2006 suggest that the same dopamine-modulated neurons in dorsolateral prefrontal cortex, which show changes in the activity during working memory tasks are those that represent duration during time perception tasks. This model provides the framework to hypothesize that the negative effects of oxycodone on working memory (Friswell et al., 2008; Cherrier et al., 2009) and time perception may be influenced by the same process in humans.
It is well documented that the interval timing is influenced by dopamine, a neurotransmitter that is modulated by opioid activity (Mansour et al., 1995) . Indirect dopamine agonists, such as methamphetamine, produce shortened temporal reproduction, perhaps due to the speeding up of the internal clock (Maricq et al., 1981; Maricq and Church, 1983; Meck, 1983; Buhusi and Meck, 2002; Matell et al., 2006) , whereas dopamine antagonists, such as haloperidol, produce longer reproductions (Meck, 1983 (Meck, , 1986 Buhusi and Meck, 2002; Drew et al., 2003) . In humans with Parkinson's disease, a disorder characterized by depletion of dopamine in the nigrostriatal pathway, timing of two intervals 'migrate' toward each other, pointing to an effect on retrieval of temporal memories (Malapani et al., , 2002 Malapani and Rakitin, 2003) .
Opioids have the ability to inhibit or stimulate dopamine release, depending on the dopamine and opioid receptor subtypes and neuroanatomical location (Mansour et al., 1995) . For instance, in the nigrostriatal and mesolimbic dopamine systems, m-opioid receptor activation stimulates dopamine release, whereas k-opioid receptor activation inhibits dopamine release. Indeed, a recent microdialysis study showed that oxycodone increases striatal dopamine in mice (Zhang et al., 2009 ). Furthermore, D2 receptors, which have been suggested to be responsible for some of dopamine's effects on timing in rats (Meck, 1986; Drew et al., 2003) , are upregulated or downregulated depending on whether the injection protocol and time frame resulted in behavioral tolerance or sensitization to a morphine challenge (Le Marec et al., 2011) . Anatomical studies showing colocalization of D2 receptors and m-opioid receptors in dorsolateral striatum (Ambrose et al., 2004) , which has been suggested to be a critical structure for interval timing (Hinton and Meck, 2004; Matell and Meck, 2004; Shea-Brown et al., 2006) , suggest that m-opioid modulation of dopaminergic activity may have profound effects on timing. Oxycodone has an affinity for both m (Yoburn et al., 1995) and k (Ross and Smith, 1997) receptor subtypes. Thus, the possibility exists that oxycodone, through its effect on m-opioid receptors, could have an effect similar to dopamine agonists on interval timing, or that some as yet unknown action through k receptors on timing may be discovered.
In the SET model, effects can broadly be divided into those that are scalar, such that variability increases proportionally with mean estimates of time, and those that are not. A finding of scalar changes with oxycodone administration is indicated by the lack of phase Â dose effects on CV in this experiment; CV did not change after drug administration. A number of mechanisms for this effect are suggested by the scalar property of the changes seen.
Oxycodone may dampen attention to time, especially as performance on the Digit Symbol Substitution Test, a measure dependent on attention, among other faculties, has been shown to be disrupted by oxycodone in healthy volunteers (Zacny and Lichtor, 2008) , and more specifically in middle aged and older adults (Cherrier et al., 2009) . In attentional-gating models, continual disruptions in attention to time would be indistinguishable from a clock-speed effect, because a loss of pacemaker 'ticks' would occur in both cases, presumably throughout the interval timed, leading to overproductions of time intervals (Zakay and Block, 1997; Fortin, 1999) . Dopamine activity, which is modulated by opiates, also has been shown to influence clock processes and attention to time (Buhusi and Meck, 2002) .
Alternatively, oxycodone could have an effect on the reference, or long-term memory for time, such that the remembered accumulator value for each time is warped to seem longer than it actually was. Such an effect would also lengthen reproductions of time intervals and thus is also consistent with the current results. One study found effects of oxycodone at a lower dose (5 mg) on memory (source identification) in women but not in men (Friswell et al., 2008) , although this effect is described as 'marginal', and a report in humans using similar doses of oxycodone to that used in this study (10-30 mg) does not support it (Zacny and Gutierrez, 2003) .
Given the scalar quality of the increases in response latency produced by oxycodone, one mechanism for this effect can be ruled out. As described briefly in the introduction, in the SET model, the pacemaker, which produces timing signals, and the accumulator, which collects these signals, are separated by an attentional 'switch' that closes when the cue to begin timing is presented, allowing pacemaker signals to make their way to the accumulator (Meck, 1983; Rakitin, 2005) . When the cue to end timing is perceived, the switch opens (or attention to time stops), stopping the flow of pacemaker ticks. In dual-task conditions, mean time productions are lengthened because the switch opens, thus executive functions can contend with the secondary task. This leads to fewer pacemaker pulses accumulated over the same time period, thus lengthening time productions. However, this opening of the switch also contributes nonscalar variability, because the variability of switch-open time is not related to the interval being timed (Rakitin, 2005) . It has been shown that opioid agonists cause reduced motor activity (Di Chiara and Imperato, 1988) . This could lead to a general slowing of motor responses, which could manifest as longer latencies to reproduce the time intervals learned. However, this would lead to proportionally greater errors in reproduction at the shorter time interval, whereas we found the opposite. Reduced error at the 1-s interval compared with the longer time intervals such as those that we found argue against a motor slowing account of our findings.
The current findings show that administration of 15 mg oxycodone orally, has a lengthening effect on reproductions of times greater than approximately 1 s. More studies are required to determine the mechanism by which the drug exerts this effect, and any discussion of how this occurs is speculative given the current results. It has been postulated that distorted time perception could impact delay discounting, or the perception of values of future outcomes, in such a way that the future seems more remote and future consequences seem less important (Takahashi, 2005 (Takahashi, , 2006 . This can lead to decision processes that give greater weight to immediate gains, producing impulsive behavior. Although administration of naltrexone (an endogenous opioid antagonist) has been shown to attenuate impulsive behavior in humans in a variety of domains (Marrazzi et al., 1995; Kim et al., 2001; Raymond et al., 2002) , a recent finding by Zacny and de Wit 2009 showed little effect on impulsive behavior, including delay discounting, by doses of oxycodone similar to that used in this study in healthy adult volunteers. This finding, in conjunction with the current results, suggests a complicated relationship between delay discounting and time perception in the seconds range, indicating that they may not be as closely tied as has been proposed (Takahashi 2005 (Takahashi , 2006 ; instead, increased rates of discounting in addicted populations may be due to some other cause.
